Becton, Dickinson and Company (BVMF:B1DX34)
Brazil flag Brazil · Delayed Price · Currency is BRL
203.57
+0.93 (0.46%)
At close: Dec 4, 2025

Becton, Dickinson and Company Company Description

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.

It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments.

It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems.

It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers.

It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products.

The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Becton, Dickinson and Company
Country United States
Founded 1897
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 72,000
CEO Thomas Polen

Contact Details

Address:
1 Becton Drive
Franklin Lakes, New Jersey 07417-1880
United States
Phone 201 847 6800
Website bd.com

Stock Details

Ticker Symbol B1DX34
Exchange Brazil Stock Exchange
Fiscal Year October - September
Reporting Currency USD
SIC Code 3841

Key Executives

Name Position
Thomas E. Polen Jr. President, Chief Executive Officer and Chairman
Christopher J. DelOrefice Executive Vice President and Chief Financial Officer
Shana Carol Neal Executive Vice President and Chief People Officer
Michael Garrison Executive Vice President and President of Medical segment
Thomas J. Spoerel Senior Vice President, Controller and Chief Accounting Officer
Elizabeth McCombs Executive Vice President and Chief Technology Officer
Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D. Senior Vice President, Chief Scientific Officer and Co-Chair of Scientific Advisory Board
Denise Russell Fleming Executive Vice President of Technology and Global Services and Chief Information Officer
Greg Rodetis Head of Investor Relations
Michelle Quinn Executive Vice President and General Counsel